您的当前位置:首页 > 行业数据 > Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势
图片属性
图片格式:PNG 图片大小:1229KB 图片尺寸:2317*968
同报告图片
 / 4
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势_第1页
55Sx5LqO5Zu+6KGo5Li65Y+v6KeG5YyW5ZGI546w77yM57K+56Gu5pWw5YC86ZyA5Z+65LqO6KeG6KeJ5Lyw566X77yM5Lul5LiL5Li657uT5p6E5YyW5pWw5o2u6KGo5qC877yI5ZCr5pe26Ze044CB5ZCE57u05bqmIHByb2plY3RlZCB2b2x1bWUg5Y+K5aKe6ZW/546H6LaL5Yq/77yJ77yaCgp8IOaXtumXtCAgICAgICB8IE1lZGljYXJlIC0gU1REIChQcm9qZWN0ZWQgVm9sdW1lKSB8IE1lZGljYXJlIC0gTElTIChQcm9qZWN0ZWQgVm9sdW1lKSB8IENvbW1lcmNpYWwgKFByb2plY3RlZCBWb2x1bWUpIHwgT3RoZXIgKFByb2plY3RlZCBWb2x1bWUpIHwgJSBOQlJ4IGdyb3d0aCAtIGNvbW1lcmNpYWwgfCAlIE5CUnggZ3Jvd3RoIC0gTWVkaWNhcmUgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMjItMDEgICAgfCB+MTAwMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjMwMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IH41MDAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjIwMCAgICAgICAgICAgICAgICAgICAgIHwgfjIwMCUgICAgICAgICAgICAgICAgICAgICAgICB8IH4xNzAlICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjItMDIgICAgfCB+MTA1MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjMyMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IH41MjAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjIxMCAgICAgICAgICAgICAgICAgICAgIHwgfjExMCUgICAgICAgICAgICAgICAgICAgICAgICB8IH44MCUgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjItMDMgICAgfCB+MTEwMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjM0MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IH41NDAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjIyMCAgICAgICAgICAgICAgICAgICAgIHwgfjE5MCUgICAgICAgICAgICAgICAgICAgICAgICB8IH43MCUgICAgICAgICAgICAgICAgICAgICAgfAp8IC4uLu+8iOS4remXtOaciOS7veecgeeVpe+8jOi2i+WKv+W7tue7re+8iS4uLiB8IC4uLiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAuLi4gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgLi4uICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAuLi4gICAgICAgICAgICAgICAgICAgICAgIHwgLi4uICAgICAgICAgICAgICAgICAgICAgICAgICB8IC4uLiAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjQtMDcgICAgfCB+MjY1MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjE0NTAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IH4xOTUwICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjc1MCAgICAgICAgICAgICAgICAgICAgIHwgfjE2MCUgICAgICAgICAgICAgICAgICAgICAgICB8IH4xODUlICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjQtMDggICAgfCB+MjcwMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjE1MDAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IH4yMDAwICAgICAgICAgICAgICAgICAgICAgICAgIHwgfjgwMCAgICAgICAgICAgICAgICAgICAgIHwgfjE4MCUgICAgICAgICAgICAgICAgICAgICAgICB8IH4xOTAlICAgICAgICAgICAgICAgICAgICAgfAoKCui1hOaWmeadpea6kO+8mklRVklB44CCTkJSeO+8muaWsOWTgeeJjOWkhOaWuQ==
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势_第2页
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势_第3页
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势_第4页
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
Amvuttra在ATTR-CM最大竞争对手Tafamidis(Vyndamax及Vyndaqel)销量及增长趋势_第5页
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
所属报告: 艾拉伦制药(ALNY.US)-美股公司研究报告:管理层交流反馈:Amvuttra全球商业化强劲推进及主要临床项目进展-251127(13页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠